Dermatophytic Onychomycosis Treatment Market Research Report Information By Product Type (Tablets and Nail Paints), By Route of Administration (Oral and Topical), By Type (Prescribed and Over-the-Counter (OTC)), By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, and Online Channels), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Tablets

6.3. Nail Paints

7. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

7.1. Overview

7.2. Oral

7.3. Topical

8. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE

8.1. Overview

8.2. Prescribed

8.3. Over-the-Counter (OTC)

9. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL

9.1. Overview

9.2. Hospitals & Clinics

9.3. Retail Pharmacies

9.4. Online Channels

10. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY REGION

10.1. Overview

10.2. North America

10.2.1. US

10.2.2. Canada

10.3. Europe

10.3.1. Germany

10.3.2. France

10.3.3. UK

10.3.4. Italy

10.3.5. Spain

10.3.6. Rest of Europe

10.4. Asia-Pacific

10.4.1. China

10.4.2. India

10.4.3. Japan

10.4.4. South Korea

10.4.5. Australia

10.4.6. Rest of Asia-Pacific

10.5. Rest of the World

10.5.1. Middle East

10.5.2. Africa

10.5.3. Latin America

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Dermatophytic Onychomycosis Treatment Market,

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Dermatophytic Onychomycosis Treatment Market,

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2022

11.8.2. Major Players R&D Expenditure. 2022

12. COMPANY PROFILES

12.1. BAUSCH HEALTH COMPANIES INC.

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Products Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Pfizer Inc.

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Products Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Galderma

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Products Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. GlaxoSmithKline plc

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Products Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Janssen Pharmaceuticals, Inc.

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Products Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. CIPLA INC.

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Products Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Kaken pharmaceuticals Co., Ltd.

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Products Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 6 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 9 NORTH AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 10 NORTH AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 11 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 12 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 13 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 14 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 15 CANADA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 16 CANADA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 17 CANADA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 18 CANADA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 3 EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 4 EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 5 GERMANY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 6 GERMANY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 7 GERMANY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 8 GERMANY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 9 FRANCE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 10 FRANCE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 11 FRANCE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 12 FRANCE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 13 ITALY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 14 ITALY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 15 ITALY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 16 ITALY: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 17 SPAIN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 18 SPAIN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 19 SPAIN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 20 SPAIN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 21 UK: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 22 UK: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 23 UK: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 24 UK: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 25 REST OF EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 26 REST OF EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 27 REST OF EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 28 REST OF EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 29 ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 30 ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 31 ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 32 ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 33 JAPAN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 34 JAPAN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 35 JAPAN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 36 JAPAN: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 37 CHINA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 38 CHINA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 39 CHINA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 40 CHINA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 41 INDIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 42 INDIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 43 INDIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 44 INDIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 45 AUSTRALIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 46 AUSTRALIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 47 AUSTRALIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 48 AUSTRALIA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 49 SOUTH KOREA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 50 SOUTH KOREA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 51 SOUTH KOREA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 52 SOUTH KOREA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 53 REST OF ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 54 REST OF ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 55 REST OF ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 56 REST OF ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 57 REST OF THE WORLD: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 58 REST OF THE WORLD: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 59 REST OF THE WORLD: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 60 REST OF THE WORLD: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 61 MIDDLE EAST: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 62 MIDDLE EAST: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 63 MIDDLE EAST: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 64 MIDDLE EAST: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 65 AFRICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 66 AFRICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 67 AFRICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 68 AFRICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 69 LATIN AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 70 LATIN AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)

TABLE 71 LATIN AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 72 LATIN AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET

FIGURE 4 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY PRODUCT TYPE, 2022

FIGURE 5 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022

FIGURE 6 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY TYPE, 2022

FIGURE 7 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022

FIGURE 8 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 NORTH AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 EUROPE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 ASIA-PACIFIC: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 REST OF THE WORLD: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022

FIGURE 13 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 14 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS

FIGURE 16 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 PFIZER INC.: SWOT ANALYSIS

FIGURE 18 GALDERMA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 GALDERMA: SWOT ANALYSIS

FIGURE 20 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 22 JANSSEN PHARMACEUTICALS, INC..: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 JANSSEN PHARMACEUTICALS, INC..: SWOT ANALYSIS

FIGURE 24 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 CIPLA INC.: SWOT ANALYSIS

FIGURE 26 KAKEN PHARMACEUTICALS CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 KAKEN PHARMACEUTICALS CO., LTD.: SWOT ANALYSIS

FIGURE 28 GENERAL ELECTRIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 GENERAL ELECTRIC: SWOT ANALYSIS

FIGURE 30 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS

FIGURE 32 CARESTREAM HEALTH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 CARESTREAM HEALTH: SWOT ANALYSIS